Data from the Tumor Cancer Genome Atlas (TCGA) cohort showed SIAH3 to be down-regulated in multiple cancers, including pancreatic adenocarcinoma (PAAD), compared to normal non-cancerous tissues (Figure 3D). This evidence concerns the gene SIAH3 and pancreatic adenocarcinoma.